Cue BioPharma
CUE----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Cue BioPharma(CUE) predict that the Revenue is 5.686 M (+1251%), Beat estimate;the EPS is -1.08 (+78.82%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B1250.59%
0.00B493.82%
+0.00B756.77%
EBIT
TBA--
-0.01B10.56%
----
EPSExceed expectations
-1.0878.82%
-3.335.29%
+2.220043.53%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf